Ken Griffin
SBFM

Ken Griffin’s Sunshine Biopharma SBFM Stock Holding History

Ken Griffin’s Portfolio SBFM Stock Details SBFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$48.1K Sell
4,625
-768
-14% -$9.05K ﹤0.01% 12418
2025
Q4 		$66.3K Sell
5,393
-2,416
-31% -$38.2K ﹤0.01% 11898
2025
Q3 		$116K Buy
7,809
+1,466
+23% +$21.7K ﹤0.01% 11734
2025
Q2 		$91.3K Buy
+6,343
New +$92.7K ﹤0.01% 11411
2024
Q2 		– Sell
-28
Closed -$33.3K – 15248
2024
Q1 		$33.3K Buy
28
+19
+211% +$55.8K ﹤0.01% 12591
2023
Q4 		$50.3K Buy
+9
New +$51.2K ﹤0.01% 11779

Other funds holding SBFM

TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Ken Griffin's SBFM Position: Q1 2026 in Review

Ken Griffin reduced its Sunshine Biopharma (SBFM) stake by 14% in Q1 2026, selling an estimated $9.05K and leaving 4,625 shares worth $48.1K. The position accounts for ﹤0.01% of the portfolio, ranked #12418.

Ken Griffin first reported a position in SBFM in Q4 2023 and has held it in 6 quarters since. The position peaked at $116K in Q3 2025. 8 funds tracked by Wall St. Rank hold SBFM as of Q1 2026.

  • Ken Griffin held 4,625 shares of Sunshine Biopharma worth $48.1K as of Q1 2026.
  • Ken Griffin sold 768 Sunshine Biopharma shares in Q1 2026, an estimated $9.05K.
  • Sunshine Biopharma made up ﹤0.01% of Ken Griffin's portfolio in Q1 2026, its #12418 holding.
  • Ken Griffin first reported a position in Sunshine Biopharma in Q4 2023 and has held it in 6 quarters since.
  • Ken Griffin's Sunshine Biopharma position peaked at $116K in Q3 2025.
  • 8 funds tracked by Wall St. Rank held Sunshine Biopharma as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.